Inotiv, Inc.
General ticker "NOTV" information:
- Sector: Health Care
- Industry: Medical - Diagnostics & Research
- Capitalization: $36.8M (TTM average)
Inotiv, Inc. does not follow the US Stock Market performance with the rate: -27.7%.
Estimated limits based on current volatility of 11.2%: low 0.01$, high 0.02$
Factors to consider:
- Total employees count: 2046 (-1.4%) as of 2025
- US accounted for 85.4% of revenue in the fiscal year ended 2024-09-30
- Top business risk factors: Going concern doubt, Regulatory and compliance, Internal control weaknesses, Litigation risks, Strategic risks and growth management
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-09-30 to 2027-09-30
- 2025-09-30 to 2026-09-30 estimated range: [0.74$, 2.31$]
- 2026-09-30 to 2027-09-30 estimated range: [0.79$, 2.40$]
Financial Metrics affecting the NOTV estimates:
- Positive: with PPE of -1.6 at the end of fiscal year the price was neutral
- Negative: negative Operating cash flow
- Negative: negative Operating income
- Positive: Industry inventory ratio change (median), % of -0.73 <= -0.15
- Positive: Shareholder equity ratio, % of 17.64 <= 19.19
Short-term NOTV quotes
Long-term NOTV plot with estimates
Financial data
| YTD | 2023-09-30 | 2024-09-30 | 2025-09-30 |
|---|---|---|---|
| Operating Revenue | $572.42MM | $490.74MM | $513.02MM |
| Operating Expenses | $653.88MM | $577.14MM | $543.93MM |
| Operating Income | $-81.46MM | $-86.41MM | $-30.90MM |
| Non-Operating Income | $-42.78MM | $-44.35MM | $-56.87MM |
| Interest Expense | $43.02MM | $46.88MM | $56.59MM |
| Income(Loss) | $-124.24MM | $-130.76MM | $-87.77MM |
| Taxes | $-19.34MM | $-21.88MM | $-19.14MM |
| Net Income(Loss)* | $-105.14MM | $-108.44MM | $-68.62MM |
| Stockholders Equity | $269.15MM | $170.50MM | $136.03MM |
| Inventory | $56.10MM | $18.17MM | $45.74MM |
| Assets | $856.53MM | $781.36MM | $771.11MM |
| Operating Cash Flow | $27.88MM | $-6.80MM | $-10.46MM |
| Capital expenditure | $27.50MM | $22.31MM | $16.61MM |
| Investing Cash Flow | $-28.75MM | $-16.83MM | $-12.89MM |
| Financing Cash Flow | $15.87MM | $9.68MM | $23.70MM |
| Earnings Per Share** | $-4.10 | $-4.19 | $-2.11 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.